196 related articles for article (PubMed ID: 32008800)
1. [Thrombosis and platelet dysfunction in myeloproliferative neoplasms].
Mornet C; Galinat H; Mingant F; Ianotto JC; Lippert E
Rev Med Interne; 2020 May; 41(5):319-324. PubMed ID: 32008800
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of bleeding and thrombosis in myeloproliferative disorders.
Landolfi R; Marchioli R; Patrono C
Thromb Haemost; 1997 Jul; 78(1):617-21. PubMed ID: 9198226
[TBL] [Abstract][Full Text] [Related]
3. [Pathogenesis of thrombosis in JAK2V617F myeloproliferative neoplasms].
Guy A; James C
Med Sci (Paris); 2019; 35(8-9):651-658. PubMed ID: 31532377
[TBL] [Abstract][Full Text] [Related]
4. [Pathogenesis of thrombotic and hemorrhagic complications in myeloproliferative and myelodysplastic syndromes].
Vlădăreanu AM; Popov V; Bumbea H; Ciufu C; Vasilache V; Petre A; Onisâi M
Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):14-9. PubMed ID: 21688554
[TBL] [Abstract][Full Text] [Related]
5. Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients.
Wehmeier A; Daum I; Jamin H; Schneider W
Ann Hematol; 1991 Aug; 63(2):101-6. PubMed ID: 1912029
[TBL] [Abstract][Full Text] [Related]
6. Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders.
Wehmeier A; Südhoff T; Meierkord F
Semin Thromb Hemost; 1997; 23(4):391-402. PubMed ID: 9263357
[TBL] [Abstract][Full Text] [Related]
7. From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms.
Stein BL; Martin K
Blood; 2019 Nov; 134(22):1902-1911. PubMed ID: 31778549
[TBL] [Abstract][Full Text] [Related]
8. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function.
Barbui T; Cortelazzo S; Viero P; Bassan R; Dini E; Semeraro N
Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1593-9. PubMed ID: 6580171
[TBL] [Abstract][Full Text] [Related]
9. Bleeding and thrombosis in chronic myeloproliferative disorders: relation of platelet disorders to clinical aspects of the disease.
Wehmeier A; Scharf RE; Fricke S; Schneider W
Haemostasis; 1989; 19(5):251-9. PubMed ID: 2777137
[TBL] [Abstract][Full Text] [Related]
10. Platelet function in myeloproliferative disorders: characterization and sequential studies show multiple platelet abnormalities, and change with time.
Baker RI; Manoharan A
Eur J Haematol; 1988 Mar; 40(3):267-72. PubMed ID: 3356243
[TBL] [Abstract][Full Text] [Related]
11. A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms.
Rungjirajittranon T; Owattanapanich W; Ungprasert P; Siritanaratkul N; Ruchutrakool T
BMC Cancer; 2019 Feb; 19(1):184. PubMed ID: 30819138
[TBL] [Abstract][Full Text] [Related]
12. Thrombocytosis and Thrombosis: Is There Really a Correlation?
Galvez C; Stein BL
Curr Hematol Malig Rep; 2020 Aug; 15(4):261-267. PubMed ID: 32399765
[TBL] [Abstract][Full Text] [Related]
13. Clinical and laboratory significance of defective P2Y(12) pathway function in patients with myeloproliferative neoplasms: a pilot study.
Chang H; Shih LY; Michelson AD; Dunn P; Frelinger AL; Wang PN; Kuo MC; Lin TL; Wu JH; Tang TC
Acta Haematol; 2013; 130(3):181-7. PubMed ID: 23751441
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of haemorrhagic and thrombotic events in myeloproliferative disorders: a retrospective study of 108 patients.
Grossi A; Rosseti S; Vannucchi AM; Rafanelli D; Ferrini PR
Clin Lab Haematol; 1988; 10(2):167-75. PubMed ID: 3416575
[TBL] [Abstract][Full Text] [Related]
15. Platelets and thrombosis in myeloproliferative diseases.
Harrison CN
Hematology Am Soc Hematol Educ Program; 2005; ():409-15. PubMed ID: 16304412
[TBL] [Abstract][Full Text] [Related]
16. Thrombosis in myeloproliferative neoplasms.
Falanga A; Marchetti M
Semin Thromb Hemost; 2014 Apr; 40(3):348-58. PubMed ID: 24610470
[TBL] [Abstract][Full Text] [Related]
17. Platelet Function, Role in Thrombosis, Inflammation, and Consequences in Chronic Myeloproliferative Disorders.
Repsold L; Joubert AM
Cells; 2021 Nov; 10(11):. PubMed ID: 34831257
[TBL] [Abstract][Full Text] [Related]
18. Thrombosis and hemorrhage in chronic myeloproliferative disorders.
Baş B; Köksal A; Ozatli D; Haznedaroğlu I; Koşar A; Büyükaşik Y; Ozcebe O; Dündar S
Clin Appl Thromb Hemost; 1999 Oct; 5(4):282-4. PubMed ID: 10726027
[No Abstract] [Full Text] [Related]
19. How to manage thrombosis in myeloproliferative neoplasms.
Barbui T
Curr Opin Oncol; 2011 Nov; 23(6):654-8. PubMed ID: 21986846
[TBL] [Abstract][Full Text] [Related]
20. Are MPNs vascular diseases?
Finazzi G; De Stefano V; Barbui T
Curr Hematol Malig Rep; 2013 Dec; 8(4):307-16. PubMed ID: 24037420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
